2008 ICD-9-CM Volume 1 Diagnosis Codes Home > Neoplasms 140-239 > Carcinoma In Situ 230-234 >
  Carcinoma in situ of breast and genitourinary system- 233 is a non-specific code that cannot be used to specify a diagnosis
  Carcinoma in situ of breast- Abnormal cells that are confined to the ducts or lobules in the breast. There are two forms, called ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS).
- Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
- 233.0 is a specific code that can be used to specify a diagnosis
- 233.0 contains 13 index entries
  Carcinoma in situ of cervix uteri- Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
- 233.1 is a specific code that can be used to specify a diagnosis
- 233.1 contains 7 index entries
  Carcinoma in situ of other and unspecified parts of uterus- 233.2 is a specific code that can be used to specify a diagnosis
  Carcinoma in situ of other and unspecified female genital organs- 233.3 is a non-specific code that cannot be used to specify a diagnosis
  Carcinoma in situ of other and unspecified female genital organs; unspecified female genital organ- 233.30 is a specific code that can be used to specify a diagnosis
  Carcinoma in situ of other and unspecified female genital organs; vagina- 233.31 is a specific code that can be used to specify a diagnosis
- 233.31 contains 3 index entries
  Carcinoma in situ of other and unspecified female genital organs; vulva- 233.32 is a specific code that can be used to specify a diagnosis
- 233.32 contains 5 index entries
  Carcinoma in situ of other and unspecified female genital organs; other female genital organ- 233.39 is a specific code that can be used to specify a diagnosis
  Carcinoma in situ of prostate- This is a clonal growth of partially transformed cells resulting in morphologically identifiable premalignant lesions. These are further subdivided into low and high-grade lesions. The alterations include loss of glandular formation with the development of more anaplastic morphology, nuclear pleomorphism, invasion of the basement membrane, an increase in cell motility, loss of contact inhibition, and angiogenesis.
- 233.4 is a specific code that can be used to specify a diagnosis
- 233.4 contains 2 index entries
  Carcinoma in situ of penis- Stage 0 includes: (Tis, N0, M0) and (Ta, N0, M0). Tis: Carcinoma in situ. Ta: Non-invasive verrucous carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003
- 233.5 is a specific code that can be used to specify a diagnosis
- 233.5 contains 2 index entries
  Carcinoma in situ of other and unspecified male genital organs- 233.6 is a specific code that can be used to specify a diagnosis
  Carcinoma in situ of bladder- Also known as carcinoma in situ of the urinary bladder or high grade intraurothelial neoplasia, this is a flat lesion of the transitional cell epithelium characterized by severe cytologic atypia. This lesion is confined to the urothelium, and is a precursor of invasive transitional cell carcinoma of the bladder. -- 2003
- 233.7 is a specific code that can be used to specify a diagnosis
  Carcinoma in situ of other and unspecified urinary organs- 233.9 is a specific code that can be used to specify a diagnosis
|
|
|